Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 15INDUSTRY 6NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Rectal Neoplasms 20Colonic Neoplasms 20Head and Neck Neoplasms 14Stomach Neoplasms 12Squamous Cell Carcinoma of Head and Neck 12Breast Neoplasms 11Esophageal Neoplasms 9Adenocarcinoma Of Esophagus 9Pancreatic Neoplasms 8Anus Neoplasms 8Anal Canal Carcinoma 6Urinary Bladder Neoplasms 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Squamous Intraepithelial Lesions 2Hepatoblastoma 2HIV Infections 2Carcinoma, Hepatocellular 2Tongue Neoplasms 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Radiation Injuries 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1

Interventions

Ultrasonography 1Preoperative Exercise 1Oxaliplatin 1Leucovorin 1Fluorouracil 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gastrointestinal Neoplasms × Fluorouracil × Clear all
NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡